GB0414894D0 - Biomarkers of alzheimer's disease - Google Patents

Biomarkers of alzheimer's disease

Info

Publication number
GB0414894D0
GB0414894D0 GBGB0414894.6A GB0414894A GB0414894D0 GB 0414894 D0 GB0414894 D0 GB 0414894D0 GB 0414894 A GB0414894 A GB 0414894A GB 0414894 D0 GB0414894 D0 GB 0414894D0
Authority
GB
United Kingdom
Prior art keywords
biomarkers
alzheimer
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0414894.6A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kings College London
Original Assignee
Kings College London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kings College London filed Critical Kings College London
Priority to GBGB0414894.6A priority Critical patent/GB0414894D0/en
Publication of GB0414894D0 publication Critical patent/GB0414894D0/en
Priority to JP2007518700A priority patent/JP2008504551A/ja
Priority to EP05756942A priority patent/EP1763674A2/en
Priority to CNA2005800225150A priority patent/CN101010589A/zh
Priority to US11/630,769 priority patent/US20080076140A1/en
Priority to BRPI0512948-6A priority patent/BRPI0512948A/pt
Priority to CA002571692A priority patent/CA2571692A1/en
Priority to AU2005258926A priority patent/AU2005258926A1/en
Priority to PCT/GB2005/002592 priority patent/WO2006003414A2/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GBGB0414894.6A 2004-07-02 2004-07-02 Biomarkers of alzheimer's disease Ceased GB0414894D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GBGB0414894.6A GB0414894D0 (en) 2004-07-02 2004-07-02 Biomarkers of alzheimer's disease
JP2007518700A JP2008504551A (ja) 2004-07-02 2005-07-01 アルツハイマー病のバイオマーカー
EP05756942A EP1763674A2 (en) 2004-07-02 2005-07-01 Biomarkers of alzheimer's disease
CNA2005800225150A CN101010589A (zh) 2004-07-02 2005-07-01 阿尔茨海默病的生物标记
US11/630,769 US20080076140A1 (en) 2004-07-02 2005-07-01 Biomarkers of Alzheimer's Disease
BRPI0512948-6A BRPI0512948A (pt) 2004-07-02 2005-07-01 biomarcadores de mal de alzheimer
CA002571692A CA2571692A1 (en) 2004-07-02 2005-07-01 Biomarkers of alzheimer's disease
AU2005258926A AU2005258926A1 (en) 2004-07-02 2005-07-01 Biomarkers of Alzheimer's disease
PCT/GB2005/002592 WO2006003414A2 (en) 2004-07-02 2005-07-01 Biomarkers of alzheimer's disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0414894.6A GB0414894D0 (en) 2004-07-02 2004-07-02 Biomarkers of alzheimer's disease

Publications (1)

Publication Number Publication Date
GB0414894D0 true GB0414894D0 (en) 2004-08-04

Family

ID=32843494

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0414894.6A Ceased GB0414894D0 (en) 2004-07-02 2004-07-02 Biomarkers of alzheimer's disease

Country Status (9)

Country Link
US (1) US20080076140A1 (enExample)
EP (1) EP1763674A2 (enExample)
JP (1) JP2008504551A (enExample)
CN (1) CN101010589A (enExample)
AU (1) AU2005258926A1 (enExample)
BR (1) BRPI0512948A (enExample)
CA (1) CA2571692A1 (enExample)
GB (1) GB0414894D0 (enExample)
WO (1) WO2006003414A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007138408A1 (en) 2006-05-25 2007-12-06 Ge Healthcare Limited 11c/18 f-labeled inhibitors of glycogen synthase kinase-3
WO2009074331A2 (en) * 2007-12-11 2009-06-18 Julius-Maximilians-Universität Würzburg Early and differential diagnosis test for alzheimer's disease
EP2279420B1 (en) 2008-03-21 2014-01-29 Manuela G. Neuman METHODS FOR THE DIFFERENTIAL DIAGNOSIS OF ALZHEIMER'S DISEASE VERSUS FRONTOTEMPORAL DEMENTIA, COMPRISING FAS-L, TNF-alpha AND ccCK-18 AS BIOMARKERS
US20100151457A1 (en) * 2008-12-17 2010-06-17 National Tsing Hua University Detection of Unhealthy Cell and Uses Thereof
US20120040361A1 (en) * 2010-07-22 2012-02-16 National Tsing Hua University Methods and compositions for detection of lethal system and uses thereof
CN104237526B (zh) * 2013-06-18 2016-08-17 磁量生技股份有限公司 一种检测阿兹海默症罹患风险的系统
US20170102398A1 (en) * 2014-03-05 2017-04-13 Humanetics Corporation Predicting and reducing cognitive decline based on gsk-3 levels
CN104698188A (zh) * 2015-03-04 2015-06-10 华中科技大学 检测人血小板GSK-3β蛋白活性的斑点印迹方法
CN111323597A (zh) * 2018-12-14 2020-06-23 陈志成 用于检测受试者中mci和/或ad的方法、试剂盒及筛选化合物的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005240669A1 (en) * 2004-05-07 2005-11-17 Garvan Institute Of Medical Research Detecting disease association with aberrant glycogen synthase kinase 3-beta expression

Also Published As

Publication number Publication date
CN101010589A (zh) 2007-08-01
WO2006003414A3 (en) 2006-03-16
BRPI0512948A (pt) 2008-04-15
JP2008504551A (ja) 2008-02-14
AU2005258926A1 (en) 2006-01-12
CA2571692A1 (en) 2006-01-12
US20080076140A1 (en) 2008-03-27
WO2006003414A2 (en) 2006-01-12
EP1763674A2 (en) 2007-03-21

Similar Documents

Publication Publication Date Title
EP1694816A4 (en) BIOMARKERS FOR ALZHEIMER BIOMARKERS DISEASE FOR ALZHEIMER'S DISEASE
EP1809601A4 (en) COMPOUNDS FOR ALZHEIMER'S DISEASE
IL188165A0 (en) Method for the diagnosis of alzheimer's disease
EP1940373B8 (en) 1-fluoro-1-deoxy-scyllo-inositol for the treatment of alzheimer's disease
EP1778618A4 (en) SYNTHESIS OF TRIETHYLENETETRAMINES
EP1855525A4 (en) FISH MODELS ZEBRA OF ALZHEIMER'S DISEASE
GB0414894D0 (en) Biomarkers of alzheimer's disease
EP1877416A4 (en) SAPOSIN D AND FAM3C ARE BIOLOGICAL MARKERS FOR ALZHEIMER DISEASE
IL180513A0 (en) Process for synthesis of 4-4'-diamino-diphenyl-sulfone
EP1711484A4 (en) SYNTHESIS OF CYANOIMINO-BENZOIMIDAZOLES
GB0400802D0 (en) Compounds for the treatment of disease
EP1601683A4 (en) NEW NON-INVASIVE MARKERS FOR LIVER DISEASES
IL189547A0 (en) Synthesis of 1??-fluoro-25-hydroxy
AU2003251962A8 (en) Screening for alzheimer's disease
GB0410101D0 (en) Parkinson's disease
EP1693671A4 (en) METHOD FOR DIAGNOSING ALZHEIMER'S DISEASE
ZA200709553B (en) Player's outfit
IL172690A0 (en) Methods for the diagnosis and prognosis of alzheimer's disease
GB2409587B (en) 'Kwicap'
GB0510474D0 (en) Q's vaginometer
EP2099476A4 (en) METHODS OF TREATING ALZHEIMER'S DISEASE
IL178184A0 (en) Synthesis of pyrrole-2-carbonitriles
HK1112247A (en) Saposin d and fam3c are biomarkers for alzheimer's disease
GB0516947D0 (en) L'eau-go
GB0511003D0 (en) Screening and treatment of alzheimer's disease

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)